[HTML][HTML] An inflammatory cytokine signature predicts COVID-19 severity and survival

…, Y Lavin, TH Swartz, D Madduri, A Stock, TU Marron… - Nature medicine, 2020 - nature.com
Several studies have revealed that the hyper-inflammatory response induced by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major cause of disease severity …

[HTML][HTML] NASH limits anti-tumour surveillance in immunotherapy-treated HCC

…, A Lujambio, JF Dufour, TU Marron… - Nature, 2021 - nature.com
Hepatocellular carcinoma (HCC) can have viral or non-viral causes 1 , 2 , 3 , 4 – 5 . Non-alcoholic
steatohepatitis (NASH) is an important driver of HCC. Immunotherapy has been …

Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma

…, E Kenigsberg, RP Deering, M Schwartz, TU Marron… - Nature medicine, 2023 - nature.com
Despite no apparent defects in T cell priming and recruitment to tumors, a large subset of T
cell rich tumors fail to respond to immune checkpoint blockade (ICB). We leveraged a …

[PDF][PDF] Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification

…, MB Beasley, H Salmon, AH Rahman, TU Marron… - Cancer cell, 2021 - cell.com
Immunotherapy is a mainstay of non-small cell lung cancer (NSCLC) management. While
tumor mutational burden (TMB) correlates with response to immunotherapy, little is known …

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: a real …

…, B Wietharn, H Hildebrand, L Wu, C Ang, TU Marron… - Hepatology, 2022 - journals.lww.com
… 4 Department of Gastroenterology and HepatologyKindai University Faculty of
MedicineOsakaJapan … 10 University Medical Center MainzMainzGermany … Dominik …

TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer

…, LF De Andrade, M Colonna, TU Marron… - Nature …, 2023 - nature.com
Natural killer (NK) cells are commonly reduced in human tumors, enabling many to evade
surveillance. Here, we sought to identify cues that alter NK cell activity in tumors. We found that…

Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination

L Hammerich, TU Marron, R Upadhyay… - Nature medicine, 2019 - nature.com
Indolent non-Hodgkin’s lymphomas (iNHLs) are incurable with standard therapy and are
poorly responsive to checkpoint blockade. Although lymphoma cells are efficiently killed by …

Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity

…, M Prahl, SL Gaw, S Gnjatic, TU Marron… - Science Translational …, 2022 - science.org
A damaging inflammatory response is implicated in the pathogenesis of severe coronavirus
disease 2019 (COVID-19), but mechanisms contributing to this response are unclear. In two …

[HTML][HTML] Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae

…, D Yuan, L Huckins, P Roussos, TU Marron… - Nature Medicine, 2023 - nature.com
Post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection are debilitating, clinically heterogeneous and of unknown molecular etiology. A …

Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors

…, MB Beasley, R Pradhan, S Muller, TU Marron… - Cancer Discovery, 2022 - AACR
The cellular and molecular programs driving T-cell marginalization in solid tumors remain
unclear. Here, we describe two CAF populations associated with T-cell exclusion in human …